NEW YORK, May 16 (GenomeWeb News) - Nanosphere said today that it has closed $57 million in a Series D financing led by Bain Capital.

 

The company will use the funding to commercialize its Verigene System, a genomic testing platform that Nanosphere said eliminates the need for PCR.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.